Eyre, Rachel
Alférez, Denis G. http://orcid.org/0000-0003-3491-4823
Santiago-Gómez, Angélica http://orcid.org/0000-0002-2946-2669
Spence, Kath
McConnell, James C.
Hart, Claire http://orcid.org/0000-0003-3833-2070
Simões, Bruno M. http://orcid.org/0000-0003-1253-6657
Lefley, Diane
Tulotta, Claudia
Storer, Joanna http://orcid.org/0000-0002-6614-9735
Gurney, Austin
Clarke, Noel
Brown, Mick http://orcid.org/0000-0003-1322-4671
Howell, Sacha J. http://orcid.org/0000-0001-8141-6515
Sims, Andrew H. http://orcid.org/0000-0001-9082-3665
Farnie, Gillian
Ottewell, Penelope D. http://orcid.org/0000-0002-4826-0771
Clarke, Robert B. http://orcid.org/0000-0001-5407-3123
Funding for this research was provided by:
Breast Cancer Now (MAN-Q1/Q2, 2016MayPR734)
RCUK | Medical Research Council (MRC-MR/P000096/1)
Article History
Received: 26 February 2019
Accepted: 2 October 2019
First Online: 1 November 2019
Competing interests
: A.G. is Chief Scientific Officer at Oncomed Pharmaceuticals. All other authors declare no competing interests.